2024 Scientific Activities Report
Héma-Québec’s scientific activities report sheds light on the scope of our organization’s scientific achievements. The projects described herein were carried out by the teams of the Vice-présidence aux affaires médicales et à l’innovation and the Vice-présidence à la médecine transfusionnelle.
Related document
2024 was a year full of projets! For instance, in response to a patient’s urgent need, Héma Québec rapidly developed a screening method to assess the expression of CD36 on the surface of HLA typed platelets. Our teams also conducted an analysis revealing that the risk of tuberculosis transmission through tissue transplantation was very low in Québec, showing the adequacy of current eligibility criteria. Our organization has also evaluated a pathogen inactivation technology that, once implemented, could alleviate—or even eliminate—some exclusion criteria for blood donation.
Consult the 2024 Scientific Activities Report